Rating History for BioCryst Pharma (BCRX) by RBC Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/10/2026 | Brian Abraham | Downgrade | Sector Perform (Outperform) |
11.00 (N/A) |
8.81 (7.79) |
-11.58% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
